Tag Archives: antiviral

AIDS: ARV Optimism Tempered by Home Truths

The prospect that antiretroviral drugs could prevent HIV infection in high-risk populations was the big news emerging from last month’s International AIDS Conference in Washington, DC. But the news raises the tricky ethical question of whether the US should spend $11,000 per patient to keep uninfected individuals healthy, when funds are lacking to provide life-saving […]
Posted in FDA, Guest Blog, healthcare | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta